Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Adrian Goldman is active.

Publication


Featured researches published by Adrian Goldman.


Structure | 1999

Of barn owls and bankers: a lush variety of α/β hydrolases

Pirkko Heikinheimo; Adrian Goldman; Cy Jeffries; David L. Ollis

Abstract α / β Hydrolase fold proteins are an important, diverse, widespread group of enzymes not yet fully exploited by structural biologists. We describe the current state of knowledge of this family, and suggest a smaller definition of the required core and some possible future avenues of exploration.


The EMBO Journal | 2004

The Yersinia adhesin YadA collagen-binding domain structure is a novel left-handed parallel beta-roll.

Heli Nummelin; Michael C. Merckel; Jack C. Leo; Hilkka Lankinen; Mikael Skurnik; Adrian Goldman

The crystal structure of the recombinant collagen‐binding domain of Yersinia adhesin YadA from Yersinia enterocolitica serotype O:3 was solved at 1.55 Å resolution. The trimeric structure is composed of head and neck regions, and the collagen binding head region is a novel nine‐coiled left‐handed parallel β‐roll. Before the β‐roll, the polypeptide loops from one monomer to the rest, and after the β‐roll the neck region does the same, making the transition from the globular head region to the narrower stalk domain. This creates an intrinsically stable ‘lock nut’ structure. The trimeric form of YadA is required for collagen binding, and mutagenesis of its surface residues allowed identification of a putative collagen‐binding surface. Furthermore, a new structure–sequence motif for YadA β‐roll was used to identify putative YadA‐head‐like domains in a variety of human and plant pathogens. Such domains may therefore be a common bacterial strategy for avoiding host response.


Proceedings of the National Academy of Sciences of the United States of America | 2011

Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement.

Tommi Kajander; Markus J. Lehtinen; Satu Hyvärinen; Arnab Bhattacharjee; Elisa Leung; David E. Isenman; Seppo Meri; Adrian Goldman; T. Sakari Jokiranta

The alternative pathway of complement is important in innate immunity, attacking not only microbes but all unprotected biological surfaces through powerful amplification. It is unresolved how host and nonhost surfaces are distinguished at the molecular level, but key components are domains 19–20 of the complement regulator factor H (FH), which interact with host (i.e., nonactivator surface glycosaminoglycans or sialic acids) and the C3d part of C3b. Our structure of the FH19–20:C3d complex at 2.3-Å resolution shows that FH19–20 has two distinct binding sites, FH19 and FH20, for C3b. We show simultaneous binding of FH19 to C3b and FH20 to nonactivator surface glycosaminoglycans, and we show that both of these interactions are necessary for full binding of FH to C3b on nonactivator surfaces (i.e., for target discrimination). We also show that C3d could replace glycosaminoglycan binding to FH20, thus providing a feedback control for preventing excess C3b deposition and complement amplification. This explains the molecular basis of atypical hemolytic uremic syndrome, where mutations on the binding interfaces between FH19–20 and C3d or between FH20 and glycosaminoglycans lead to complement attack against host surfaces.


The EMBO Journal | 2006

Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.

T. Sakari Jokiranta; Veli-Pekka Jaakola; Markus J. Lehtinen; Maria Pärepalo; Seppo Meri; Adrian Goldman

Factor H (FH) is the key regulator of the alternative pathway of complement. The carboxyl‐terminal domains 19–20 of FH interact with the major opsonin C3b, glycosaminoglycans, and endothelial cells. Mutations within this area are associated with atypical haemolytic uremic syndrome (aHUS), a disease characterized by damage to endothelial cells, erythrocytes, and kidney glomeruli. The structure of recombinant FH19–20, solved at 1.8 Å by X‐ray crystallography, reveals that the short consensus repeat domain 20 contains, unusually, a short α‐helix, and a patch of basic residues at its base. Most aHUS‐associated mutations either destabilize the structure or cluster in a unique region on the surface of FH20. This region is close to, but distinct from, the primary heparin‐binding patch of basic residues. By mutating five residues in this region, we show that it is involved, not in heparin, but in C3b binding. Therefore, the majority of the aHUS‐associated mutations on the surface of FH19–20 interfere with the interaction between FH and C3b. This obviously leads to impaired control of complement attack on plasma‐exposed cell surfaces in aHUS.


Proceedings of the National Academy of Sciences of the United States of America | 2010

Structural determinants of growth factor binding and specificity by VEGF receptor 2

Veli-Matti Leppänen; Andrea E. Prota; Michael Jeltsch; Andrey Anisimov; Nisse Kalkkinen; Tomas Strandin; Hilkka Lankinen; Adrian Goldman; Kurt Ballmer-Hofer; Kari Alitalo

Vascular endothelial growth factors (VEGFs) regulate blood and lymph vessel formation through activation of three receptor tyrosine kinases, VEGFR-1, -2, and -3. The extracellular domain of VEGF receptors consists of seven immunoglobulin homology domains, which, upon ligand binding, promote receptor dimerization. Dimerization initiates transmembrane signaling, which activates the intracellular tyrosine kinase domain of the receptor. VEGF-C stimulates lymphangiogenesis and contributes to pathological angiogenesis via VEGFR-3. However, proteolytically processed VEGF-C also stimulates VEGFR-2, the predominant transducer of signals required for physiological and pathological angiogenesis. Here we present the crystal structure of VEGF-C bound to the VEGFR-2 high-affinity-binding site, which consists of immunoglobulin homology domains D2 and D3. This structure reveals a symmetrical 2∶2 complex, in which left-handed twisted receptor domains wrap around the 2-fold axis of VEGF-C. In the VEGFs, receptor specificity is determined by an N-terminal alpha helix and three peptide loops. Our structure shows that two of these loops in VEGF-C bind to VEGFR-2 subdomains D2 and D3, while one interacts primarily with D3. Additionally, the N-terminal helix of VEGF-C interacts with D2, and the groove separating the two VEGF-C monomers binds to the D2/D3 linker. VEGF-C, unlike VEGF-A, does not bind VEGFR-1. We therefore created VEGFR-1/VEGFR-2 chimeric proteins to further study receptor specificity. This biochemical analysis, together with our structural data, defined VEGFR-2 residues critical for the binding of VEGF-A and VEGF-C. Our results provide significant insights into the structural features that determine the high affinity and specificity of VEGF/VEGFR interactions.


Journal of Cell Biology | 2008

Structure of the actin-depolymerizing factor homology domain in complex with actin

Ville O. Paavilainen; Esko Oksanen; Adrian Goldman; Pekka Lappalainen

Actin dynamics provide the driving force for many cellular processes including motility and endocytosis. Among the central cytoskeletal regulators are actin-depolymerizing factor (ADF)/cofilin, which depolymerizes actin filaments, and twinfilin, which sequesters actin monomers and caps filament barbed ends. Both interact with actin through an ADF homology (ADF-H) domain, which is also found in several other actin-binding proteins. However, in the absence of an atomic structure for the ADF-H domain in complex with actin, the mechanism by which these proteins interact with actin has remained unknown. Here, we present the crystal structure of twinfilins C-terminal ADF-H domain in complex with an actin monomer. This domain binds between actin subdomains 1 and 3 through an interface that is conserved among ADF-H domain proteins. Based on this structure, we suggest a mechanism by which ADF/cofilin and twinfilin inhibit nucleotide exchange of actin monomers and present a model for how ADF/cofilin induces filament depolymerization by weakening intrafilament interactions.


Science | 2012

The structure and catalytic cycle of a sodium-pumping pyrophosphatase

Juho Kellosalo; Tommi Kajander; Konstantin Kogan; Kisun Pokharel; Adrian Goldman

View of a Sodium Pump Membrane-integral pyrophosphatases (M-PPases) found in plants, protozoans, bacteria, and archaea, link pyrophosphate hydrolysis or synthesis to sodium or proton pumping and contribute to generating an electrochemical potential across the membrane. Kellosalo et al. (p. 473) report the structure of the sodium pumping M-PPase from Thermotoga maritima in the resting state with product bound. The structures reveal the conformational changes that are likely to accompany pyrophosphate binding and provide insight into the ion-pumping mechanism. Structures of a Thermotoga maritima sodium ion–pumping, membrane-integral pyrophosphatase provide a model of the pumping mechanism. Membrane-integral pyrophosphatases (M-PPases) are crucial for the survival of plants, bacteria, and protozoan parasites. They couple pyrophosphate hydrolysis or synthesis to Na+ or H+ pumping. The 2.6-angstrom structure of Thermotoga maritima M-PPase in the resting state reveals a previously unknown solution for ion pumping. The hydrolytic center, 20 angstroms above the membrane, is coupled to the gate formed by the conserved Asp243, Glu246, and Lys707 by an unusual “coupling funnel” of six α helices. Comparison with our 4.0-angstrom resolution structure of the product complex suggests that helix 12 slides down upon substrate binding to open the gate by a simple binding-change mechanism. Below the gate, four helices form the exit channel. Superimposing helices 3 to 6, 9 to 12, and 13 to 16 suggests that M-PPases arose through gene triplication.


Structure | 2000

Buried Charged Surface in Proteins

Tommi Kajander; Peter C. Kahn; Sari Helin Passila; Daniel C. Cohen; Lari Lehtiö; William Adolfsen; Jim Warwicker; Ursula Schell; Adrian Goldman

BACKGROUND The traditional picture of charged amino acids in globular proteins is that they are almost exclusively on the outside exposed to the solvent. Buried charges, when they do occur, are assumed to play an essential role in catalysis and ligand binding, or in stabilizing structure as, for instance, helix caps. RESULTS By analyzing the amount and distribution of buried charged surface and charges in proteins over a broad range of protein sizes, we show that buried charge is much more common than is generally believed. We also show that the amount of buried charge rises with protein size in a manner which differs from other types of surfaces, especially aromatic and polar uncharged surfaces. In large proteins such as hemocyanin, 35% of all charges are greater than 75% buried. Furthermore, at all sizes few charged groups are fully exposed. As an experimental test, we show that replacement of the buried D178 of muconate lactonizing enzyme by N stabilizes the enzyme by 4.2 degrees C without any change in crystallographic structure. In addition, free energy calculations of stability support the experimental results. CONCLUSIONS Nature may use charge burial to reduce protein stability; not all buried charges are fully stabilized by a prearranged protein environment. Consistent with this view, thermophilic proteins often have less buried charge. Modifying the amount of buried charge at carefully chosen sites may thus provide a general route for changing the thermophilicity or psychrophilicity of proteins.


Protein Engineering Design & Selection | 2009

The structure of the conserved neurotrophic factors MANF and CDNF explains why they are bifunctional

Vimal Parkash; Päivi Lindholm; Johan Peränen; Nisse Kalkkinen; Esko Oksanen; Mart Saarma; Veli-Matti Leppänen; Adrian Goldman

We have solved the structures of mammalian mesencephalic astrocyte-derived neurotrophic factor (MANF) and conserved dopamine neurotrophic factor (CDNF). CDNF protects and repairs midbrain dopaminergic neurons in vivo; MANF supports their survival in culture and is also cytoprotective against endoplasmic reticulum (ER) stress. Neither protein structure resembles any known growth factor but the N-terminal domain is a saposin-like lipid-binding domain. MANF and CDNF may thus bind lipids or membranes. Consistent with this, there are two patches of conserved lysines and arginines. The natively unfolded MANF C-terminus contains a CKGC disulphide bridge, such as reductases and disulphide isomerases, consistent with a role in ER stress response. The structure thus explains why MANF and CDNF are bifunctional; neurotrophic activity may reside in the N-terminal domain and ER stress response in the C-terminal domain. Finally, we identified three changes, (MANF)I10-->K(CDNF), (MANF)E79-->M(CDNF) and (MANF)K88-->L(CDNF), that may account for the biological differences between the proteins.


Structure | 1995

How to make my blood boil

Adrian Goldman

Two recent papers comparing the structure of a hyperthermophilic protein with its mesophilic counterpart both conclude that large networks of ion-pairs are important for hyperthermostability. How and why is not yet clear.

Collaboration


Dive into the Adrian Goldman's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge